Vitae Pharmaceuticals: Wells Fargo Securities Healthcare Conference (Vitae Pharma, 11th Annual Wells Fargo Securities Healthcare Conference) - Sep 17, 2016 - "Clear and consistent signal of efficacy from PASI score changes in both the 350mg and 700mg dose groups"
P2a data • Psoriasis
|